Ruxolitinib Cream for Vitiligo in Pakistan—Well Mart

Ruxolitinib cream is a topical JAK inhibitor approved for treating non-segmental vitiligo. It helps Repigmentation  skin by reducing immune-driven inflammation and promoting melanocyte regeneration. In patients who are unable to use other medications for their condition or whose eczema has not responded to another medication, topical ruxolitinib is used to treat the symptoms of eczema (atopic dermatitis), a skin disease that causes the skin to be dry and itchy and occasionally develop red, scaly rashes.

Ingredients:

Benefits:

• Promotes repigmentation by reducing inflammation that hinders melanocyte activity.
• Effective for facial and non-facial vitiligo, particularly in early stages.
• Provides a non-invasive treatment option.
• FDA-approved, ensuring clinical efficacy and safety.

How to Use:

• Apply a thin layer of Ruxolitinib cream to depigmented areas twice daily, as directed by your healthcare provider.
• Avoid applying on broken or infected skin.
• Wash hands before and after application unless treating hands.
• Results typically appear after 24 weeks, with significant improvements over time.
• Protect treated areas from excessive sun exposure, using sunscreen as needed.